Agilent Technologies, Inc. (0HAV.L)
0HAV.L Stock Price Chart
Explore Agilent Technologies, Inc. interactive price chart. Choose custom timeframes to analyze 0HAV.L price movements and trends.
0HAV.L Company Profile
Discover essential business fundamentals and corporate details for Agilent Technologies, Inc. (0HAV.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
IPO Date
29 Jan 2018
Employees
17.90K
Website
https://www.agilent.comCEO
Padraig McDonnell
Description
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
0HAV.L Financial Timeline
Browse a chronological timeline of Agilent Technologies, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 26 May 2026
Upcoming earnings on 24 Feb 2026
Upcoming earnings on 24 Nov 2025
Upcoming earnings on 19 Aug 2025
Revenue estimate is $1.66B.
Dividend declared on 1 Jul 2025
A dividend of $0.25 per share was announced, adjusted to $0.25. The dividend will be paid on 23 Jul 2025.
Earnings released on 28 May 2025
EPS came in at $1.31 surpassing the estimated $1.26 by +3.97%, while revenue for the quarter reached $1.67B, beating expectations by +2.56%.
Dividend declared on 1 Apr 2025
A dividend of $0.25 per share was announced, adjusted to $0.25. The dividend was paid on 23 Apr 2025.
Earnings released on 26 Feb 2025
EPS came in at $1.11 falling short of the estimated $1.28 by -13.28%, while revenue for the quarter reached $1.68B, beating expectations by +1.84%.
Dividend declared on 31 Dec 2024
A dividend of $0.25 per share was announced, adjusted to $0.25. The dividend was paid on 22 Jan 2025.
Earnings released on 26 Nov 2024
EPS came in at $1.46 surpassing the estimated $1.41 by +3.55%, while revenue for the quarter reached $1.69B, beating expectations by +1.10%.
Dividend declared on 1 Oct 2024
A dividend of $0.24 per share was announced, adjusted to $0.24. The dividend was paid on 23 Oct 2024.
Earnings released on 22 Aug 2024
EPS came in at $0.97 falling short of the estimated $1.26 by -23.10%, while revenue for the quarter reached $1.58B, beating expectations by +1.32%.
Dividend declared on 2 Jul 2024
A dividend of $0.24 per share was announced, adjusted to $0.24. The dividend was paid on 24 Jul 2024.
Earnings released on 30 May 2024
EPS came in at $1.05 falling short of the estimated $1.19 by -11.76%, while revenue for the quarter reached $1.57B, missing expectations by -0.56%.
Dividend declared on 1 Apr 2024
A dividend of $0.24 per share was announced, adjusted to $0.24. The dividend was paid on 24 Apr 2024.
Earnings released on 14 Mar 2024
EPS came in at $1.18 falling short of the estimated $1.22 by -3.28%, while revenue for the quarter reached $1.66B, beating expectations by +4.45%.
Earnings released on 9 Jan 2024
EPS came in at $1.62 surpassing the estimated $1.34 by +20.90%, while revenue for the quarter reached $1.69B, beating expectations by +1.17%.
Dividend declared on 29 Dec 2023
A dividend of $0.24 per share was announced, adjusted to $0.24. The dividend was paid on 24 Jan 2024.
Dividend declared on 2 Oct 2023
A dividend of $0.23 per share was announced, adjusted to $0.23. The dividend was paid on 25 Oct 2023.
Earnings released on 16 Aug 2023
EPS came in at $0.38 falling short of the estimated $1.36 by -72.33%, while revenue for the quarter reached $1.67B, beating expectations by +0.72%.
Dividend declared on 30 Jun 2023
A dividend of $0.23 per share was announced, adjusted to $0.23. The dividend was paid on 26 Jul 2023.
Earnings released on 24 May 2023
EPS came in at $1.02 falling short of the estimated $1.26 by -19.05%, while revenue for the quarter reached $1.72B, beating expectations by +2.00%.
Dividend declared on 3 Apr 2023
A dividend of $0.23 per share was announced, adjusted to $0.23. The dividend was paid on 26 Apr 2023.
Earnings released on 1 Mar 2023
EPS came in at $1.19 falling short of the estimated $1.31 by -9.16%, while revenue for the quarter reached $1.76B, beating expectations by +3.29%.
Earnings released on 20 Dec 2022
EPS came in at $1.23 falling short of the estimated $1.38 by -10.87%, while revenue for the quarter reached $1.85B, beating expectations by +5.06%.
Earnings released on 31 Aug 2022
EPS came in at $1.10 falling short of the estimated $1.20 by -8.33%, while revenue for the quarter reached $1.72B, beating expectations by +4.92%.
Earnings released on 27 May 2022
EPS came in at $0.91 falling short of the estimated $1.12 by -18.75%, while revenue for the quarter reached $1.61B, missing expectations by -0.58%.
Earnings released on 3 Mar 2022
EPS came in at $0.93, while revenue for the quarter reached $1.67B.
Earnings released on 17 Dec 2021
EPS came in at $1.45 surpassing the estimated $1.18 by +22.88%, while revenue for the quarter reached $1.66B, beating expectations by +0.38%.
Earnings released on 31 Aug 2021
EPS came in at $0.86, while revenue for the quarter reached $1.59B.
Earnings released on 28 May 2021
EPS came in at $0.70, while revenue for the quarter reached $1.53B.
Earnings released on 2 Mar 2021
EPS came in at $0.93, while revenue for the quarter reached $1.55B.
Earnings released on 18 Dec 2020
EPS came in at $0.71, while revenue for the quarter reached $1.48B.
Earnings released on 1 Sept 2020
EPS came in at $0.64, while revenue for the quarter reached $1.26B.
0HAV.L Stock Performance
Access detailed 0HAV.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.